For the Inventor, By the Inventor

Enter assignee name

Ballerup, Denmark

Leo Pharmaceutical Products, Ltd.

USPTO Granted Patents = 33

% Expired Patents = 12.1

Forward Citations = 349

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Ernst T Binderup (7 out of 16 patents)

Ole Bent Nielsen (7 out of 11 patents)

Martin John Calverley (4 out of 14 patents)

4. Ian Ahnfelt-Ronne (4 out of 4 patents)

5. Wagn O Godtfredsen (4 out of 12 patents)

6. Welf Von Daehne (3 out of 19 patents)

7. Erik T Hansen (3 out of 8 patents)

8. Peter Werner Feit (3 out of 9 patents)

9. Henrik Pedersen (2 out of 4 patents)

10. Schneur Rachlin (2 out of 5 patents)

11. Claus Aage Bretting (2 out of 6 patents)

12. Herta Bruun (2 out of 6 patents)

13. Sven Liisberg (2 out of 3 patents)

14. Gunnar Grue-Sørensen (1 out of 9 patents)

15. Erik Rytter Ottosen (1 out of 16 patents)

Core Competencies:

Vitamin D Derivatives

MMP Inhibitors

Osteoporosis Treatment

Aminobenzophenones

Topical Preparations

Antibacterial Compounds

Quinolines

Pharmaceutical Compositions

Serotonin Antagonists

Bisphosphonic Acids

Opthalmic Gel

Sulfamylbenzoic Acids

33 patents: Sort by Forward Citations

1. 7071178 - Use of vitamin D-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives (2006-07-04),

2. 6897236 - Aminobenzophenones as inhibitors of IL-1β and TNF-α (2005-05-24),

3. 6784169 - MMP inhibitors (2004-08-31),

4. 6537980 - Vitamin D analogues and their pharmaceutical use (2003-03-25),

5. 6310226 - Vitamin D analogues (2001-10-30),

6. D446720 - Package (2001-08-22),

7. 6255299 - Opthalmic gel composition and method of treating eye infections (2001-07-03),

8. 5763426 - Crystalline form of a vitamin D analogue (1998-06-09),

9. 5696140 - N-cyano-N'-pyridylguanidines as serotonin antagonists (1997-12-09),

10. 5554599 - 22-thio vitamin D derivatives (1996-09-10),

11. 5447924 - Vitamin D analogues (1995-09-05),

12. 5292727 - Use of the treatment of acne (1994-03-08),

13. 5244664 - Topical preparation for treatment of alopecia (1993-09-14),

14. 5234932 - Substituted quinolines and leucotriene antagonism treatment therewith (1993-08-10),

15. 5206229 - Vitamin D analogues (1993-04-27),

Company Overview

Leo Pharmaceutical Products, Ltd. is a global healthcare company headquartered in Ballerup, Denmark, specializing in dermatology and critical care. The organization focuses on developing innovative treatments for skin diseases, including psoriasis and eczema, leveraging advanced research in biopharmaceuticals. With a commitment to improving patient outcomes, Leo Pharma emphasizes collaboration and scientific excellence, aiming to address unmet medical needs in various therapeutic areas across international markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

33 Patents

#9 in Ballerup

#97 in Denmark

#20,162 in the World

Ballerup, Denmark

Leo Pharmaceutical Products, Ltd.

Forward Citations = 349

36 inventors:

Ernst T Binderup (7 out of 16 patents)

Ole Bent Nielsen (7 out of 11 patents)

Martin John Calverley (4 out of 14 patents)

4. Ian Ahnfelt-Ronne (4 out of 4 patents)

5. Wagn O Godtfredsen (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Leo Pharmaceutical Products, Ltd.. Retrieved from https://idiyas.com/company/leo-pharmaceutical-products

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…